KVP Capital Advisors, LP

CIK 0001858198 · SAN FRANCISCO, CA · Quarter end: 2026-06-30 · Filed on: 2026-08-13 · Open the SEC source

KVP Capital Advisors, LP reported 35 positions worth $136.2M as of June 30, 2026 (13F filed August 13, 2026). Largest holding: PRAX (10.5%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$136.2M
2026 Q2
Positions
35
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
57.4%
Est. Net Flow (Q)
2026 Q2
10 / 35 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1PRAXPRAXIS PRECISION MEDICINES ISH$14.4M10.54%42,900
2WHWKWHITEHAWK THERAPEUTICS INCSH$9.9M7.28%2,165,997
3ERASERASCA INCSH$8.3M6.12%455,000
4TRVITREVI THERAPEUTICS INCSH$7.7M5.67%414,000
5STROSUTRO BIOPHARMA INCSH$7.5M5.52%226,575
6TNGXTANGO THERAPEUTICS INCSH$7.2M5.28%230,264
7MBXMBX BIOSCIENCES INCSH$6.7M4.92%121,524
8PTGXPROTAGONIST THERAPEUTICS INCSH$6.5M4.77%53,000
9EWTXEDGEWISE THERAPEUTICS INCSH$5.4M3.97%133,000
10TNDMTANDEM DIABETES CARE INCSH$4.5M3.33%301,000

The free plan shows the top 10 positions. The remaining 25 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does KVP Capital Advisors, LP hold as of Q2 2026?

KVP Capital Advisors, LP reported 35 positions worth $136.2M in its Q2 2026 13F filing. Largest positions: PRAX (10.5%), WHWK (7.3%), ERAS (6.1%), TRVI (5.7%) and STRO (5.5%).

What did KVP Capital Advisors, LP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did KVP Capital Advisors, LP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.